Literature DB >> 19737230

Impaired activation of Stat1 and c-Jun as a possible defect in macrophages of patients with active tuberculosis.

H Esquivel-Solís1, F Quiñones-Falconi, A Zarain-Herzberg, R I Amieva-Fernández, Y López-Vidal.   

Abstract

Studies of patients with active tuberculosis (TB) and infected healthy individuals have shown that interferon (IFN)-gamma is present in sites of Mycobacterium tuberculosis infection in comparable levels. This suggests that there is a deficiency in the macrophage response to IFN-gamma in TB patients. We used recombinant human IFN-gamma to stimulate adherent monocyte-derived macrophages from three groups of people: patients with active tuberculosis (TBP), their healthy household contacts (HHC) and healthy uninfected controls from the community (CC). We then evaluated the ability of the macrophages to inhibit the growth of M. tuberculosis H37Rv as well as their cytokine profile at early in infection (48 h). After IFN-gamma treatment, macrophages of healthy individuals (HHC and CC) controlled M. tuberculosis growth and produced mainly nitric oxide (NO) and interleukin (IL)-12p70, whereas TBP macrophages did not kill M. tuberculosis. Additionally, TBP macrophages produced low levels of NO and IL-12p70 and high levels of tumour necrosis factor (TNF)-alpha and IL-10. Transforming growth factor (TGF)-beta levels were similar among all three groups. M. tuberculosis infection had little effect on the cytokine response after IFN-gamma stimulus, but infection alone induced more IL-10 and TGF-beta in TBP macrophages. There were no differences in Stat1 nuclear translocation and DNA binding between the groups. However, the phosphorylated Stat1 and c-Jun (AP-1) in nuclear protein extracts was diminished in TBP macrophages compared to macrophages of healthy individuals. These results indicate an impairment of Stat1-dependent and Stat1-independent IFN-gamma signalling in macrophages of people with active tuberculosis, suggesting a different molecular regulation that could impact macrophage functionality and disease outcome.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19737230      PMCID: PMC2759058          DOI: 10.1111/j.1365-2249.2009.03985.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  52 in total

1.  Identification and characterization of a novel monocyte subpopulation in human peripheral blood.

Authors:  B Passlick; D Flieger; H W Ziegler-Heitbrock
Journal:  Blood       Date:  1989-11-15       Impact factor: 22.113

2.  Local production of tumor necrosis factor and IFN-gamma in tuberculous pleuritis.

Authors:  P F Barnes; S J Fong; P J Brennan; P E Twomey; A Mazumder; R L Modlin
Journal:  J Immunol       Date:  1990-07-01       Impact factor: 5.422

3.  Identification of nitric oxide synthase as a protective locus against tuberculosis.

Authors:  J D MacMicking; R J North; R LaCourse; J S Mudgett; S K Shah; C F Nathan
Journal:  Proc Natl Acad Sci U S A       Date:  1997-05-13       Impact factor: 11.205

4.  Mycobacterial growth and sensitivity to H2O2 killing in human monocytes in vitro.

Authors:  P Laochumroonvorapong; S Paul; C Manca; V H Freedman; G Kaplan
Journal:  Infect Immun       Date:  1997-11       Impact factor: 3.441

5.  Apoptosis of human monocytes/macrophages in Mycobacterium tuberculosis infection.

Authors:  R Placido; G Mancino; A Amendola; F Mariani; S Vendetti; M Piacentini; A Sanduzzi; M L Bocchino; M Zembala; V Colizzi
Journal:  J Pathol       Date:  1997-01       Impact factor: 7.996

6.  Cytokine production at the site of disease in human tuberculosis.

Authors:  P F Barnes; S Lu; J S Abrams; E Wang; M Yamamura; R L Modlin
Journal:  Infect Immun       Date:  1993-08       Impact factor: 3.441

7.  Evidence for a Th1-like bronchoalveolar T-cell subset and predominance of interferon-gamma gene activation in pulmonary tuberculosis.

Authors:  D S Robinson; S Ying; I K Taylor; A Wangoo; D M Mitchell; A B Kay; Q Hamid; R J Shaw
Journal:  Am J Respir Crit Care Med       Date:  1994-04       Impact factor: 21.405

8.  Absence of a prominent Th2 cytokine response in human tuberculosis.

Authors:  Y Lin; M Zhang; F M Hofman; J Gong; P F Barnes
Journal:  Infect Immun       Date:  1996-04       Impact factor: 3.441

9.  Disseminated tuberculosis in interferon gamma gene-disrupted mice.

Authors:  A M Cooper; D K Dalton; T A Stewart; J P Griffin; D G Russell; I M Orme
Journal:  J Exp Med       Date:  1993-12-01       Impact factor: 14.307

10.  An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection.

Authors:  J L Flynn; J Chan; K J Triebold; D K Dalton; T A Stewart; B R Bloom
Journal:  J Exp Med       Date:  1993-12-01       Impact factor: 14.307

View more
  5 in total

1.  Selective inhibition of IFNG-induced autophagy by Mir155- and Mir31-responsive WNT5A and SHH signaling.

Authors:  Sahana Holla; Mariola Kurowska-Stolarska; Jagadeesh Bayry; Kithiganahalli Narayanaswamy Balaji
Journal:  Autophagy       Date:  2013-12-10       Impact factor: 16.016

2.  Anti-inflammatory Effects of Herbal Preparations STW5 and STW5-II in Cytokine-Challenged Normal Human Colon Cells.

Authors:  Mathias Schneider; Thomas Efferth; Heba Abdel-Aziz
Journal:  Front Pharmacol       Date:  2016-10-26       Impact factor: 5.810

3.  Interferon-Gamma Improves Macrophages Function against M. tuberculosis in Multidrug-Resistant Tuberculosis Patients.

Authors:  Taj Ali Khan; Humaira Mazhar; Shamim Saleha; Hamid Nawaz Tipu; Niaz Muhammad; Muhammad Nasser Abbas
Journal:  Chemother Res Pract       Date:  2016-07-12

4.  The blood transcriptional signature for active and latent tuberculosis.

Authors:  Min Deng; Xiao-Dong Lv; Zhi-Xian Fang; Xin-Sheng Xie; Wen-Yu Chen
Journal:  Infect Drug Resist       Date:  2019-01-30       Impact factor: 4.003

5.  Interleukin 26 Skews Macrophage Polarization Towards M1 Phenotype by Activating cJUN and the NF-κB Pathway.

Authors:  Yi-Hsuan Lin; Yi-Hsun Wang; Yi-Jen Peng; Feng-Cheng Liu; Gu-Jiun Lin; Shing-Hwa Huang; Huey-Kang Sytwu; Chia-Pi Cheng
Journal:  Cells       Date:  2020-04-10       Impact factor: 6.600

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.